INFLARX N.V. EO 0,12 WKN: A2H7A5 ISIN: NL0012661870 Kürzel: IFRX Forum: Aktien Thema: Hauptdiskussion

Warum 🤔 ?

Ich vermute, ab dem 3. Feb läuft es hier besser.........

Gestern war nicht so unsere Tag🤔

Ja Conferenz ist auch so ne Sache

Weiß man nie

Prinzipiell sollte es steigen,,,,,,,,,,,aber wissen wir, was die Amis wollen.......

Heute Morgen auch noch mal bei 3,60 nachgelegt. Habe aber auch noch eine Order für 2,95 drin stehen......für den Fall, dass das Gap noch geschlossen werden sollte.

Invitation to InflaRx Virtual R&D event on Vilobelimab for the Treatment of Hidradenitis Suppurativa We are pleased to invite you to our virtual R&D event to provide insight on the development of vilobelimab in Hidradenitis Suppurativa (HS), including details on the Phase III study design and primary endpoint. The event will take place virtually on Thursday, February 3, 2022 from 8:30 AM EST/2:30 PM CET to 10:30 AM EST/4:30 PM CET. To participate in the event, please pre-register here and you will receive a dedicated link and dial-in details to easily and quickly access the call. In addition to InflaRx executives, Christopher Sayed, MD, Associate Professor of Dermatology, University of North Carolina School of Medicine, Chapel Hill, NC, will speak at the event. Dr. Sayed is a dermatology specialist with extensive experience in the treatment of HS. He will discuss the disease and its impact on patients, including the need for new treatment options to fight the disease and improve patient quality of life. Further Information on the event can be found on the Company’s website in the Investors – Events & Presentations section. If you have questions, please contact: InflaRx N.V.

News diesen Monat noch

🎁🎁🎁

Alles unter 4 € ist Geschenk

Was für ein Rebound

Wow

Live Übertragung

J.p Morgan Conferenz 17.15

Kommen News ?